Impact of a Novel Molecular Imaging Modality, Prostate-Specific Membrane Antigen Positron Emission Tomography, on the Management of Prostate Cancer.
作者信息
Patel Neal A, Reiter Robert E
机构信息
Institute of Urologic Oncology, University of California, Los Angeles, CA.
Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA.
出版信息
J Clin Oncol. 2022 May 1;40(13):1497-1499. doi: 10.1200/JCO.21.02940. Epub 2022 Feb 24.
Abstract
摘要
相似文献
1
Impact of a Novel Molecular Imaging Modality, Prostate-Specific Membrane Antigen Positron Emission Tomography, on the Management of Prostate Cancer.一种新型分子成像方式——前列腺特异性膜抗原正电子发射断层扫描对前列腺癌治疗的影响
J Clin Oncol. 2022 May 1;40(13):1497-1499. doi: 10.1200/JCO.21.02940. Epub 2022 Feb 24.
2
Re: 'Prostate-specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy'.回复：“除多参数磁共振成像和活检外，使用前列腺特异性膜抗原正电子发射断层扫描来选择适合聚焦治疗的前列腺癌患者” 。
BJU Int. 2024 Apr;133 Suppl 4:23-24. doi: 10.1111/bju.16263. Epub 2024 Jan 4.
3
Prostate Cancer: Prostate-specific Membrane Antigen Positron-emission Tomography/Computed Tomography or Positron-emission Tomography/Magnetic Resonance Imaging for Staging.前列腺癌：用于分期的前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描或正电子发射断层扫描/磁共振成像
Top Magn Reson Imaging. 2020 Feb;29(1):59-66. doi: 10.1097/RMR.0000000000000229.
4
Detection Rate of Prostate Specific Membrane Antigen Tracers for Positron Emission Tomography/Computerized Tomography in Prostate Cancer Biochemical Recurrence: A Systematic Review and Network Meta-Analysis.前列腺特异性膜抗原示踪剂在前列腺癌生化复发中的正电子发射断层扫描/计算机断层扫描检测率：系统评价和网络荟萃分析。
J Urol. 2021 Feb;205(2):356-369. doi: 10.1097/JU.0000000000001369. Epub 2020 Sep 16.
5
Evolving Role of Prostate-Specific Membrane Antigen-Positron Emission Tomography in Metastatic Hormone-Sensitive Prostate Cancer: More Questions than Answers?前列腺特异性膜抗原正电子发射断层扫描在转移性激素敏感性前列腺癌中的角色演变：问题多于答案？
J Clin Oncol. 2022 Sep 10;40(26):3011-3014. doi: 10.1200/JCO.22.00208. Epub 2022 Apr 19.
6
The Impact of 68Ga-PSMA PET/CT and PET/MRI on the Management of Prostate Cancer.68Ga-PSMA PET/CT 和 PET/MRI 对前列腺癌管理的影响。
Urology. 2019 Aug;130:1-12. doi: 10.1016/j.urology.2019.04.004. Epub 2019 Apr 12.
7
How does Ga-prostate-specific membrane antigen positron emission tomography/computed tomography impact the management of patients with prostate cancer recurrence after surgery?Ga-前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描如何影响前列腺癌手术后复发患者的治疗？
Int J Urol. 2019 Aug;26(8):804-811. doi: 10.1111/iju.14012. Epub 2019 May 13.
8
Prostate-specific Membrane Antigen Positron Emission Tomography in the Staging of Newly Diagnosed Prostate Cancer: Is More Sensitivity Always Better?前列腺特异性膜抗原正电子发射断层扫描在新发前列腺癌分期中的应用：更高的敏感度是否总是更好？
Eur Urol. 2023 Jun;83(6):481-483. doi: 10.1016/j.eururo.2023.01.024. Epub 2023 Feb 10.
9
Patterns of Failure in Men With Radiorecurrent Prostate Cancer: A Post Hoc Analysis of 3 Prospective Gallium 68 Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography Imaging Trials.放射性复发前列腺癌男性患者的失败模式：3项前瞻性镓68前列腺特异性膜抗原正电子发射断层扫描/计算机断层扫描成像试验的事后分析
Int J Radiat Oncol Biol Phys. 2023 Aug 1;116(5):1079-1084. doi: 10.1016/j.ijrobp.2023.02.039. Epub 2023 Mar 1.
10
[Prostate-specific membrane antigen positron emission tomography (PSMA PET) for urologists-when and which tracer?].[泌尿外科医生使用前列腺特异性膜抗原正电子发射断层扫描（PSMA PET）——何时使用以及使用哪种示踪剂？]
Urologe A. 2022 Apr;61(4):384-391. doi: 10.1007/s00120-022-01766-y. Epub 2022 Feb 9.
引用本文的文献
1
Predictive value of volumetric parameters based on F-PSMA-1007 PET/CT for prostate cancer metastasis.基于F-PSMA-1007 PET/CT的体积参数对前列腺癌转移的预测价值。
Front Oncol. 2024 Feb 26;14:1335205. doi: 10.3389/fonc.2024.1335205. eCollection 2024.
本文引用的文献
1
Considerations on Integrating Prostate-Specific Membrane Antigen Positron Emission Tomography Imaging Into Clinical Prostate Cancer Trials by National Clinical Trials Network Cooperative Groups.关于将前列腺特异性膜抗原正电子发射断层成像整合到国家临床试验网络合作组进行的临床前列腺癌试验中的思考。
J Clin Oncol. 2022 May 1;40(13):1500-1505. doi: 10.1200/JCO.21.02440. Epub 2022 Jan 11.
2
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.镥 177-PSMA-617 治疗转移性去势抵抗性前列腺癌。
N Engl J Med. 2021 Sep 16;385(12):1091-1103. doi: 10.1056/NEJMoa2107322. Epub 2021 Jun 23.
3
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.高风险前列腺癌患者在接受根治性手术或放疗前的前列腺特异性膜抗原 PET-CT（proPSMA）：一项前瞻性、随机、多中心研究。
Lancet. 2020 Apr 11;395(10231):1208-1216. doi: 10.1016/S0140-6736(20)30314-7. Epub 2020 Mar 22.
4
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial.68Ga-PSMA-11 PET 定位复发性前列腺癌的准确性评估：一项前瞻性单臂临床试验。
JAMA Oncol. 2019 Jun 1;5(6):856-863. doi: 10.1001/jamaoncol.2019.0096.
5
Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis.镓 68 前列腺特异性膜抗原正电子发射断层扫描在晚期前列腺癌中的应用——更新的诊断效用、敏感性、特异性和前列腺特异性膜抗原阳性病变的分布：系统评价和荟萃分析。
Eur Urol. 2020 Apr;77(4):403-417. doi: 10.1016/j.eururo.2019.01.049. Epub 2019 Feb 14.
6
Impact of Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence.镓-PSMA-11 PET/CT 对生化复发前列腺癌患者管理的影响。
J Nucl Med. 2018 Mar;59(3):434-441. doi: 10.2967/jnumed.117.202945. Epub 2017 Dec 14.
7
Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy.用于成像和治疗的前列腺特异性膜抗原配体
J Nucl Med. 2017 Sep;58(Suppl 2):67S-76S. doi: 10.2967/jnumed.116.186767.
8
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer.转移性激素敏感性前列腺癌的化学激素疗法
N Engl J Med. 2015 Aug 20;373(8):737-46. doi: 10.1056/NEJMoa1503747. Epub 2015 Aug 5.
9
The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis.CT和MRI对前列腺癌患者盆腔淋巴结分期的诊断准确性：一项荟萃分析。
Clin Radiol. 2008 Apr;63(4):387-95. doi: 10.1016/j.crad.2007.05.022. Epub 2008 Feb 4.
10
Prostate-specific membrane antigen expression in normal and malignant human tissues.前列腺特异性膜抗原在正常和恶性人类组织中的表达。
Clin Cancer Res. 1997 Jan;3(1):81-5.
Zotero 插件